Application

19323258 · CD40L-SPECIFIC TN3-DERIVED SCAFFOLDS FOR THE TREATMENT AND PREVENTION OF SJÖGREN'S SYNDROME

Filed 2025-09-09 · Granted The official file ↗ · Art unit 1674 · Examiner Xiaozhen Xie Typical · CPC A61K 38/16 · VIELA BIO, INC. · AMGEN INC.

Office actions

first was Notice of allowance

RCEs

no appeal

To first action

12.0 mo

to disposition 12.0 mo

Statutes raised

0 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.